Oncotarget

Research Papers:

Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas

Enusha Karunasena, Lauren J. McIver, Brian R. Rood, Xiaowei Wu, Hongxiao Zhu, Jasmin H. Bavarva and Harold R. Garner _

PDF  |  HTML  |  Supplementary Files  |  Order a Reprint

Oncotarget. 2014; 5:6003-6014. https://doi.org/10.18632/oncotarget.2076

Metrics: PDF 1127 views  |   HTML 1680 views  |   ?  


Abstract

Enusha Karunasena1,*, Lauren J. McIver1,*, Brian R. Rood2, Xiaowei Wu3, Hongxiao Zhu3, Jasmin H. Bavarva1 and Harold R. Garner1

1 Virginia Bioinformatics Institute, Medical Informatics and Systems Division; Blacksburg, VA

2 Center for Cancer and Blood Disorders at Children’s National Medical Center; Washington, D.C

3 Department of Statistics at Virginia Tech; Blacksburg, VA

* These authors contributed equally to this work

Correspondence:

Harold R. Garner, email:

Keywords: GBM; microsatellite; glioma; oligodendroglioma; helicase; ubiquitin proteasome system

Received: March 3, 2014 Accepted: June 4, 2014 Published: June 5, 2014

Abstract

Genomic studies of glioma sub-types have amassed new disease specific mutations, yet these only partially explain how mutations are linked to predisposition or progression. We hypothesized that microsatellite variation could expand the understanding of glioma etiology. Furthermore, germline markers for gliomas are typically undetectable; therefore we also hypothesize that the predictability of cancer-associated microsatellite loci in germline DNA may support the current hypothesis of a glioma cell of origin.

In this study, “normal” germline exome sequenced DNA from the 1000 Genomes Project (n=390) were compared with exome sequences from germlines of subjects with WHO grade II and III lower-grade glioma (LGG, n=136) and WHO grade IV glioblastoma (GBM, n=252) from The Cancer Genome Atlas to identify microsatellite loci non-randomly associated with glioma. From germline data, we identified 48 GBM-specific loci, 42 Lower-grade glioma specific loci and 29 loci that distinguish GBM from LGG (p≤ 0.01). We then attempted to distinguish WHO grade II glioma (n=67) from GBM resulting in 8 informative loci. Significantly, in all glioma grades, comparisons between tumor and matched germline sequences demonstrated no significant differences in these variants (p≥ 0.01). Therefore, these microsatellite loci are considered to be components of grade-specific signatures for glioma which distinguish germline sequences of individuals with cancer from those of individuals that are “normal”. In order to better understand the significance of these loci, we identified biological processes enriched in genes with these variants. Most strikingly, six helicase genes were enriched in the GBM cohort (p≤ 1.0 x10-3). The preservation of these glioma-specific loci could therefore serve as valuable diagnostic and therapeutic markers; especially since the heterogeneity of tumor cell populations can obscure the identification of mutations preceding a metastatic phenotype.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 2076